Pay in 4 interest-free payments of $6.38 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Molecular Identity Class Growth Hormone Releasing Peptide (GHRP) Mechanism Stimulates pituitary gland GH release Distinguishing Feature Selective GH release without affecting cortisol or prolactin Research Context Ipamorelin research has examined: GH secretion patterns: Studies show pulsatile GH release mimicking natural patterns Selectivity: Unlike earlier GHRPs, Ipamorelin shows minimal effect on cortisol and prolactin Recovery research: Some studies have examined applications in tissue repair models Ipamorelin is not FDA-approved and remains a research compound in the United States
Roughly 80 people have received BPC-157 across five published studies
In animal models of heart failure, BPC-157 showed some cardioprotective signals, but these were recorded in specific injury contexts, not in healthy cardiovascular systems exposed to supraphysiologic peptide concentrations
Ice numbs the injection site and reduces pain during needle insertion, while heat after injection can ease post-injection soreness and promote blood flow
Aberrant hydroxymethylation of ANGPTL4 is associated with selective intrauterine growth restriction in monochorionic twin pregnancies
